Abbott Laboratories (NYSE: ABT) is among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company has a strong presence in healthcare and its diabetes care division, with the FreeStyle Libre product line, has seen record-breaking sales. Additionally, Abbott Labs has a 53-year track record of dividend growth, making it a reliable option for investors.

Read more at Yahoo Finance: How Abbott Laboratories (ABT) Balances Innovation with Shareholder Payouts